MMed in Radiation Oncology Overview
MMed in Radiation Oncology Overview
Before a candidate can sit for the Part II examination, the head of the Division of Radiation Oncology must confirm that the candidate has spent adequate time in training, completed a logbook of training, and successfully completed the research assignment. This endorsement ensures that candidates are prepared and meet the necessary experiential requirements .
Not completing the Part I and Part II examinations within specified timeframes (18 and 60 months, respectively) implies a lack of progress in the MMed (Rad Onc) programme, potentially hindering graduation and career advancement. Extension of training time under exceptional circumstances might be considered by the Postgraduate Committee, evidencing the programme's commitment to timely competency development and qualification .
The programme ensures continuous professional development and independent thinking by mandating rigorous evaluation components, including a comprehensive research assignment and clinical examinations. It encourages candidates to engage with current medical literature and apply findings to practice, aligning training with the professional expectations of the Health Professions Council of South Africa and international standards .
The four-year MMed (Rad Onc) programme is structured to achieve its educational objectives by integrating extensive clinical training with rigorous examinations and a research component. This aligns with the programme's goals to ensure comprehensive cancer management training, foster independent thinking, and enhance decision-making skills, thereby fulfilling both national and international healthcare standards .
Success in the MMed (Rad Onc) programme is determined by the equal contribution of marks from the Part I and Part II examinations and the research assignment. The research assignment must be submitted six months before graduation. Moreover, the candidate must pass the Part I and Part II examinations within specified periods from the commencement of training (18 months and 60 months, respectively).
Part I of the examinations includes a written examination after a minimum of six months in a recognised registrar training programme. Part II consists of a written examination, an objective structured clinical examination (OSCE), and an oral examination, requiring a minimum of 36 months' training in a recognised registrar programme. Additionally, a research assignment must be completed successfully before the Part II examination .
The equal weighting of examinations and research assignments highlights the programme's holistic assessment approach, valuing both theoretical knowledge and practical research skills. It ensures candidates are not only proficient in clinical practice but are also capable contributors to the academic and research community, fostering a well-rounded radiation oncology expertise .
The key objectives of the MMed (Rad Onc) programme include training medical doctors in the non-surgical management of cancers to a standard that meets the requirements of the Health Professions Council of South Africa and other related bodies, ensuring the provision of comprehensive patient care, stimulating independent thinking, promoting responsibility for professional development, enhancing skills in literature interpretation and application, and decision-making skills in radiation, chemotherapy, and surgical interventions .
The research assignment is a critical component, ensuring that candidates engage in scholarly activities. To complete the MMed (Rad Onc) programme, candidates must submit either a full-length assignment or a prepared manuscript for a peer-reviewed journal. This assignment contributes equally with the Part I and Part II examinations to the final results. It must be successfully completed, along with sufficient time spent in training, to gain the head of Division's endorsement for the Part II examination .
The programme content of the MMed (Rad Onc) includes Part I subjects like Anatomy, Radiobiology, and Radiological Physics, and Part II subjects such as Radiotherapy and Radio-isotopes. These areas are designed to provide a comprehensive foundation in both theoretical and applied aspects of radiation oncology .